How Can the Gut Microbiota Contribute to Liver Disease?

Microbes that reside in colons of obese individuals produce many compounds that could contribute to development of non-alcoholic fatty liver disease (NAFLD) and other complications of obesity, according to a study published in the July issue of Clinical Gastroenterology and Hepatology. Microorganisms living in the human intestine (gut microbiota) affect

Read more

Could Intestinal Microbes Reduce Insulin Resistance?

The intestinal microbiota can be manipulated to increase insulin sensitivity in people with metabolic syndrome, according to a study published in the October issue of Gastroenterology. The trillions of microorganisms that reside in the human intestine are important regulators of metabolism. Changes in their composition and metabolic function have been

Read more

Fecal Transplantation for C difficile Infection?

Transplantation of feces, via colonoscopy, can cure patients with recurring Clostridium difficile infection (CDI) — even those with the virulent C difficile 027 strain—according to the March issue of Gastroenterology. CDI is a common cause of diarrhea in patients taking antibiotics. Infections have recently become more frequent, severe, refractory to treatment and likely

Read more

What Does the Appendix Do, Anyway?

The appendix protects against recurrent infection by Clostridium difficile (C difficile) and possibly other pathogenic bacteria, according to a study published in the December issue of Clinical Gastroenterology and Hepatology. Although the human appendix is considered to be expendable, it contains gut-associated lymphoid tissue (GALT), which processes antigen and regulates

Read more